.Kailera Therapeutics has actually introduced in to the progressively packed weight problems room al...
.With early stage 1 records today out in the wild, metabolic condition clothing Metsera is actually ...
.Rivus Pharmaceuticals has actually unveiled the information responsible for its phase 2 obesity suc...
.Bristol Myers Squibb is paying for Perfect Medicine $110 million ahead of time to build reagents fo...
.Novartis has tattooed a deal likely worth much more than $1 billion along with Flagship-founded Gen...
.Recently debuted Metsera is actually unfolding some phase 1 data for its GLP-1 receptor agonist, ex...
.Surrounded by the genetic medicines arms race, Main Pioneering is revealing a brand new company to ...
.BioAge Labs is actually considering about $180 million in preliminary profits coming from an IPO an...
.An effort through Merck & Co. to unlock the microsatellite steady (MSS) metastatic colon cancer ...
.Spain-based Asabys Partners has closed a fund of 180 thousand europeans ($ 200 million), amount of ...
.BioAge Labs is actually bringing in almost $200 million by means of its Nasdaq IPO today, along wit...
.Welcome to this week's Chutes & Ladders, our roundup of considerable management hirings, firings...
.Cassava Sciences has consented to pay for $40 million to address an investigation right into insura...
.Merck & Co. has grabbed possibilities on two Evaxion Biotech injection candidates, spending $3.2...
.Enanta Pharmaceuticals has actually connected its own respiratory syncytial infection (RSV) antivir...
.Biogen has conducted the last ceremonies to its partnership along with Sage Therapies on SAGE-324, ...
.On the exact same time that some Parkinson's ailment medicines are actually being actually cast dou...
.On the heels of a $3 billion fund coming from Bain Capital Life Sciences, Arc Venture Partners is a...
.Finnish biotech Orion has spied possible in Aitia's "electronic twin" technology to build brand new...
.While Windtree Rehabs has struggled to increase the economic origins needed to survive, a phase 2 g...